Acuson (ACN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acuson (ACN)

ACN 248.46

-0.7%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Fisher who wrote (22)	7/30/1997 8:02:00 PM
From: Liatris Spicata	of 55

Jim- Don't know why stock hasn't moved. I did receive a Schwab company research report on ACN a few days ago. It mentioned an order a few months back from Diagnostic Health Services of 22 systems Aspen series machines and noted it was the largest order in ACN's history. S&P has a three star rating (hold) on ACN and puts their Earnings and Divident Ranking at B-, two notches below average. In the Valuation category, the report noted ACN has having five year annual growth in revenues of 1%, as compared with 10% for its industry (Scientific Instruments). It also noted a book value of $6.91. On 7/17 a Jonathan Osgood of Alex Brown upgraded ACN from "buy" to "strong buy". For the three months ending 4/30/97 institutions owned 43.2% of ACN, while company insiders were net sellers. As of 7/24, the report showed nine analysts following the company: one had a hold, three were "buy/hold" and five had a "hold". I recall seeing in Monday's IBD that some firm (Bear/Stearns) upgraded its recommendation on ACN. Larry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next